To investigate whether CCTA can improve the diagnostic work-up of patients with acute chest pain and inconclusively elevated high-sensitivity troponins (hs-troponins), particularly those with low-range positive results.
Key Findings:
CCTA serves as a non-invasive alternative to ICA, effectively reducing unnecessary invasive procedures.
A significant proportion of patients (20-30%) fall into the inconclusive category, representing a heterogeneous group with an unfavorable prognosis.
CCTA can identify significant CAD (≥ 50% stenosis) in patients with inconclusive hs-troponin results.
Interpretation:
CCTA improves diagnostic accuracy for patients with acute chest pain and inconclusive hs-troponin levels, potentially leading to better management and outcomes.
Limitations:
Study conducted in a specific geographic area, which may limit generalizability, particularly for populations with different demographics.
Exclusion of patients with prior CAD history may affect the applicability of findings, as this group may have different risk profiles.
Conclusion:
CCTA is a valuable tool for assessing patients with acute chest pain and inconclusive hs-troponin results, potentially improving patient management.
by Murat Arslan, Jeroen Schaap, Bart van Gorsel, Anton Aubanell, Ricardo P. J. Budde, Alexander Hirsch, Martijn W. Smulders, Casper Mihl, Peter Damman, Olga Sliwicka, Jesse Habets, Eric A. Dubois, Admir Dedic
